Supernus Pharmaceuticals (NASDAQ:SUPN) announces a private offering of $75M in Convertible...

Supernus Pharmaceuticals (NASDAQ:SUPN) announces a private offering of $75M in Convertible Senior Notes due 2019, with a 30-day option to purchase up to an additional $15M. The notes are being secured by liens on substantially all of SUPN's assets. Shares -14% AH.